Geron Corp (NAS:GERN)
$ 4.54 0.06 (1.34%) Market Cap: 2.74 Bil Enterprise Value: 2.46 Bil PE Ratio: 0 PB Ratio: 8.90 GF Score: 35/100

Q4 2021 Geron Corp Earnings Call Transcript

Mar 10, 2022 / 09:30PM GMT
Release Date Price: $1.1 (+1.85%)
Operator

Ladies and gentlemen, thank you for standing, and welcome to the Geron Corporation Fourth Quarter Fiscal 2021 Earnings Call. (Operator Instructions) Olivia Bloom, you may begin your conference.

Olivia Kyusuk Bloom
Geron Corporation - Executive VP of Finance, CFO & Treasurer

Good afternoon, everyone. Welcome to the Geron Corporation Fourth Quarter and Year-end 2021 Conference Call. I'm Olivia Bloom, Geron's Chief Financial Officer. I'm joined today by Dr. John Scarlett, Geron's Chairman and Chief Executive Officer; Dr. Aleksandra Rizo, Geron's Executive Vice President and Chief Medical Officer; and Anil Kapur, Geron's Executive Vice President of Corporate Strategy and Chief Commercial Officer.

Before we begin, please note that during the course of this presentation and question-and-answer session, we will be making forward-looking statements regarding future events, performance, plans, expectations and other projections including those relating to the therapeutic potential and potential regulatory approval of imetelstat, anticipated clinical and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot